Consistently, in vivo assays revealed that IGF2BP3 knockdown attenuated the RCC cancer stemness and inhibited orthotopic xenografts growth while overexpression of circRARS impaired the inhibition (Figures 7A,B and S16A). The gene discussed is IGF2BP3; the disease is cancer.